[Histological progression of paucibacillary leprosy during treatment with various therapeutic regimens].
Histopathological examination of skin biopsies from PB patients during the first 12-18 months of treatment did not reveal any significant difference in the time necessary for disappearance of the lesions. The regimens studied were: DDS 100 mg 7/7, RMP 600 mg 1/30 6x, RMP 600 mg 6/6 6x, RMP 900 mg 1/7 8x and 12x, RMP 1500 mg 1x and 1 year of DDS, RMP 4 mg/K 1x.
Pattyn
S R
SR
Husser
J A
JA
Janssens
L
L
Nollet
E
E
D001706:Biopsy; D003622:Dapsone / Q000627:therapeutic use*; D006801:Humans; D007918:Leprosy / Q000188:drug therapy / Q000473:pathology*; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*; D012867:Skin / Q000473:pathology
D003622:Dapsone; D012293:Rifampin
Evolution histologique de la lèpre paucibacillaire au cours du traitement par divers régimes thérapeutiques.